These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1153262)

  • 21. The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules.
    Scott Morton F
    Rand J Econ; 1997; 28(2):269-90. PubMed ID: 11794358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacy: how cost-effective are generics?
    Wolfe H
    Hospitals; 1973 May; 47(9):100-8. PubMed ID: 4702078
    [No Abstract]   [Full Text] [Related]  

  • 23. PBS charges.
    Harvey K
    Med J Aust; 1991 Mar; 154(5):364-5. PubMed ID: 2017069
    [No Abstract]   [Full Text] [Related]  

  • 24. The economics of drug prescribing in Ireland.
    O'Hanrahan M; O'Malley K
    Ir Med J; 1981 Oct; 74(10):309-10, 312. PubMed ID: 7309452
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of generics will mean cost savings.
    Nelson G
    Internist; 1979 May; 20(4):6-8. PubMed ID: 10242132
    [No Abstract]   [Full Text] [Related]  

  • 26. The Maximum Allowable Cost program--some marketing consequences.
    Gosselin RA
    Med Mark Media; 1978 Feb; 13(2):19-20, 22, 24 passim. PubMed ID: 10306394
    [No Abstract]   [Full Text] [Related]  

  • 27. [Collective fines for over-prescription? A German model for reduced use of antibiotics].
    Kamme C; Mölstad S
    Lakartidningen; 1994 Nov; 91(47):4366, 4369-71. PubMed ID: 7808143
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of our drug consumption in various so-called geriatrie diseases].
    Krankemann G
    Dtsch Gesundheitsw; 1968 Oct; 23(41):1938-40. PubMed ID: 5712783
    [No Abstract]   [Full Text] [Related]  

  • 31. IMS updates HMM's pharmacy indexes.
    Doyle JJ
    Hosp Mater Manage; 1991 Jan; 16(1):19-22. PubMed ID: 10170632
    [No Abstract]   [Full Text] [Related]  

  • 32. Economic problems in drug distribution.
    Rucker TD
    Inquiry; 1972 Sep; 9(3):43-50. PubMed ID: 4262974
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmaceuticals: pharmaceutical cost controls--2005. End of Year Issue Brief.
    Seay M; Varma P
    Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Health care cost control by third party payors: fee schedules and the Sherman Act.
    Kallstrom DW
    Duke Law J; 1978 May; (2):645-97. PubMed ID: 10239068
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative approaches to pharmaceutical price regulation in the European Union.
    Mrazek MF
    Croat Med J; 2002 Aug; 43(4):453-61. PubMed ID: 12187524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic vs. brand name drugs--quality, not cost, is key issue.
    Stetler CJ
    Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmacoeconomic aspects of bronchial asthma].
    Prosekova EV; Gel'tser BI; Shestovskaia TN
    Ter Arkh; 2000; 72(3):55-8. PubMed ID: 10776656
    [No Abstract]   [Full Text] [Related]  

  • 38. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of generic drug competition on the price of prescription drugs in Ontario.
    Lexchin J
    CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug pricing by hospital pharmacies: a preliminary study.
    Silverman M; Lydecker M
    Am J Hosp Pharm; 1974 Sep; 31(9):870-5. PubMed ID: 4418446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.